|
|
Article: TARGETED GENETICS NAMES BRUCE H. DEVENS DIRECTOR OF IMMUNOLOGY
- Article from:
- PR Newswire
- Article date:
- December 7, 1995
CopyrightCOPYRIGHT 1995 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE, Dec. 7 /PRNewswire/ -- Targeted Genetics Corporation (Nasdaq: TGEN) has named Bruce H. Devens, Ph.D. to the position of director of immunology. He will have responsibility for directing Targeted Genetics' immunology department, and will play a critical role in directing the company's cytotoxic T lymphocyte (CTL)-based immunotherapy program.
Dr. Devens, who holds a doctorate in experimental pathology from the University of California, Los Angeles, has focused his research on immune regulation and the role of the immune system in human disease.
Dr. Devens joins Targeted Genetics from Syntex Discovery Research where he was most recently senior ...